Scarica l'app Stockscreener
0.69
4.52%
-0.0327
Dopo l'orario di chiusura:
.70
0.01
+1.45%
Precedente Chiudi:
$0.7227
Aprire:
$0.6962
Volume 24 ore:
110.55K
Relative Volume:
0.95
Capitalizzazione di mercato:
$5.14M
Reddito:
-
Utile/perdita netta:
$-16.28M
Rapporto P/E:
-0.0496
EPS:
-13.91
Flusso di cassa netto:
$-13.75M
1 W Prestazione:
-15.20%
1M Prestazione:
-14.98%
6M Prestazione:
-38.94%
1 anno Prestazione:
-81.04%
Intervallo 1D:
$0.6505
$0.71
Intervallo di 1 settimana:
$0.6505
$0.8392
Portata 52W:
$0.65
$3.85
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Nome
Pasithea Therapeutics Corp
Settore
Industria
Telefono
(702) 514-4174
Indirizzo
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Confronta KTTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.69 | 5.38M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pasithea Therapeutics Corp Borsa (KTTA) Ultime notizie
Custom strategy builders for tracking Pasithea Therapeutics Corp.Earnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com
Combining price and volume data for Pasithea Therapeutics Corp.Fed Meeting & Real-Time Chart Pattern Alerts - newser.com
Backtesting results for Pasithea Therapeutics Corp. Equity Warrant trading strategiesGap Up & Risk Adjusted Swing Trade Ideas - newser.com
Pasithea Therapeutics Corp. stock trend forecast2025 Short Interest & Target Return Focused Stock Picks - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant stock trade at a discount to peersWeekly Trend Report & Fast Entry High Yield Tips - newser.com
Chart based analysis of Pasithea Therapeutics Corp. Equity Warrant trends2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
Should you hold or exit Pasithea Therapeutics Corp. Equity Warrant now2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Can Pasithea Therapeutics Corp. Equity Warrant stock beat market expectations this quarter2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com
Is Pasithea Therapeutics Corp. stock cheap compared to fundamentalsWeekly Stock Recap & Weekly Return Optimization Alerts - newser.com
Will Pasithea Therapeutics Corp. stock outperform tech sector in 20252025 Macro Impact & Verified Momentum Stock Ideas - newser.com
Can Pasithea Therapeutics Corp. stock outperform in 2025 bull marketVolume Spike & Precise Buy Zone Identification - newser.com
What institutional flow reveals about Pasithea Therapeutics Corp. Equity WarrantMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Real time scanner hits for Pasithea Therapeutics Corp. Equity Warrant explainedJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com
Real time social sentiment graph for Pasithea Therapeutics Corp. Equity WarrantPortfolio Performance Summary & Real-Time Volume Spike Alerts - newser.com
Pasithea Therapeutics Corp.’s volatility index tracking explainedWeekly Profit Analysis & Reliable Volume Spike Trade Alerts - newser.com
Is Pasithea Therapeutics Corp. stock a buy for dividend growth2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
Automated trading signals detected on Pasithea Therapeutics Corp. Equity Warrant2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Pasithea Therapeutics Corp. stock chart pattern explainedTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
How currency fluctuations impact Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Earnings & Long-Term Safe Return Strategies - newser.com
Why Pasithea Therapeutics Corp. stock could be next big winnerMarket Movers & Weekly Hot Stock Watchlists - fcp.pa.gov.br
Pasithea Therapeutics Corp. Equity Warrant stock trend outlook and recovery pathQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How Pasithea Therapeutics Corp. stock performs in interest rate cyclesRate Hike & Breakout Confirmation Alerts - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock see insider buyingEarnings Recap Summary & Weekly Stock Performance Updates - fcp.pa.gov.br
Has Pasithea Therapeutics Corp. formed a bullish divergenceJuly 2025 Spike Watch & Weekly Top Performers Watchlists - newser.com
Multi factor analysis applied to Pasithea Therapeutics Corp.July 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Using data tools to time your Pasithea Therapeutics Corp. Equity Warrant exitJuly 2025 Volume & Fast Gaining Stock Reports - newser.com
How Pasithea Therapeutics Corp. Equity Warrant stock trades during market volatilityJuly 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock continue dividend increasesEarnings Overview Report & Precise Buy Zone Tips - newser.com
Can Pasithea Therapeutics Corp. stock attract ESG capital inflowsDividend Hike & Safe Capital Growth Stock Tips - newser.com
What earnings revisions data tells us about Pasithea Therapeutics Corp.2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock supported by strong cash flowsForecast Cut & Low Drawdown Momentum Trade Ideas - newser.com
VIX Spike: How Pasithea Therapeutics Corp. stock compares to growth peers2025 Market Trends & Community Consensus Trade Signals - fcp.pa.gov.br
Can swing trading help recover from Pasithea Therapeutics Corp. lossesAnalyst Upgrade & Short-Term High Return Strategies - newser.com
KTTA stock touches 52-week low at $1.32 amid market challenges - MSN
How Pasithea Therapeutics Corp. stock compares to growth peersPortfolio Update Report & Fast Exit Strategy with Risk Control - fcp.pa.gov.br
Will Pasithea Therapeutics Corp. stock keep outperforming rivalsOil Prices & Safe Entry Momentum Stock Tips - fcp.pa.gov.br
Pasithea activates new clinical trial site for NF1 treatment study - Investing.com India
Is Pasithea Therapeutics Corp. stock a safe investment in uncertain marketsMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Pasithea activates new clinical trial site for NF1 treatment study By Investing.com - Investing.com Australia
Will Pasithea Therapeutics Corp. Equity Warrant stock outperform value stocksTrade Ideas & Long-Term Investment Growth Plans - newser.com
Short interest data insights for Pasithea Therapeutics Corp.2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock positioned for long term growthJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Pasithea Therapeutics Corp Azioni (KTTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):